Internal Medicine, Nephrology · Harlingen, TX
NPI
1821045600
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4402 E Sesame Dr
Harlingen, TX, 78550
Phone (956) 412-1125
Groups this clinician bills Medicare through
Medicare paid, 2024
$722K
9,789 services
Medicare patients, 2024
624
Average age 72
Drug cost, 2024
$2.0M
8,484 prescriptions
Company payments, 2025
$619
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brajesh Bhatla was code 99214 (office e&m - established), 1,557 times for 370 patients. In total Brajesh Bhatla billed 9,789 services in 36 codes, and Medicare paid $722K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,557 | 370 | $95.06 | $148K |
| 99232 Hospital E&M - Subsequent | Facility | 1,364 | 212 | $63.57 | $87K |
| 82044 Clinical Chemistry | Office | 1,123 | 291 | $6.07 | $6,821 |
| 82570 Clinical Chemistry | Office | 1,120 | 291 | $5.05 | $5,656 |
| 90960 ESRD Related Services (not dialysis) | Office | 921 | 121 | $280.27 | $258K |
| 85018 Blood Count | Office | 872 | 265 | $2.32 | $2,019 |
| 99233 Hospital E&M - Subsequent | Facility | 709 | 215 | $95.72 | $68K |
| 36415 Venipuncture Blood Collection | Office | 579 | 287 | $8.64 | $5,000 |
| 90935 Hemodialysis | Facility | 278 | 79 | $57.17 | $16K |
| 90937 Hemodialysis | Facility | 209 | 80 | $82.14 | $17K |
| 99223 Hospital E&M - Initial | Facility | 190 | 161 | $139.68 | $27K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 160 | 26 | $48.34 | $7,734 |
| 99222 Hospital E&M - Initial | Facility | 113 | 76 | $105.45 | $12K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 99 | 99 | $73.92 | $7,318 |
| G0008 Administration of influenza virus vaccine | Office | 81 | 81 | $30.65 | $2,482 |
By year: 2022 $990K for 13,102 services; 2023 $781K for 10,641 services; 2024 $722K for 9,789 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82044 Clinical Chemistry | 1,123 | 291 | $6.07 | $6,821 |
| 82570 Clinical Chemistry | 1,120 | 291 | $5.05 | $5,656 |
| 85018 Blood Count | 872 | 265 | $2.32 | $2,019 |
| 36415 Venipuncture Blood Collection | 579 | 287 | $8.64 | $5,000 |
Medicare prescription drug claims, 2024
In 2024, the drug Brajesh Bhatla prescribed most often to Medicare patients was Amlodipine Besylate, with 632 prescriptions and refills. In total Brajesh Bhatla wrote 8,484 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 632 | 1,118 | 164 | $2,679 |
| Losartan Potassium Generic | 559 | 988 | 146 | $3,656 |
| Farxiga Dapagliflozin Propanediol | 545 | 640 | 103 | $338K |
| Sevelamer Carbonate Generic | 514 | 899 | 176 | $185K |
| Metoprolol Succinate Generic | 449 | 699 | 93 | $5,088 |
| Torsemide Generic | 304 | 435 | 73 | $3,982 |
| Atorvastatin Calcium Generic | 301 | 536 | 74 | $1,813 |
| Carvedilol Generic | 299 | 519 | 67 | $1,549 |
| Lisinopril Generic | 200 | 401 | 59 | $925 |
| Gabapentin Generic | 174 | 215 | 49 | $883 |
| Velphoro Sucroferric Oxyhydroxide | 167 | 222 | 60 | $593K |
| Hydralazine Hcl Generic | 154 | 270 | 40 | $1,442 |
| Furosemide Generic | 145 | 258 | 55 | $838 |
| Pantoprazole Sodium Generic | 143 | 237 | 52 | $966 |
| Tamsulosin Hcl Generic | 143 | 253 | 37 | $1,835 |
Brand drugs: 1,757 claims; generic drugs: 6,685 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brajesh Bhatla $619 ($619 in general payments such as food, travel and fees) from 13 companies. The largest payer was Akebia Therapeutics Inc with $176.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 10 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $75.22 |
| Fresenius USA Marketing, Inc. | 3 | $74.7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62.55 |
| Amgen Inc. AMGN | 3 | $51.06 |
| Novo Nordisk Inc NVO | 2 | $41.91 |
| Calliditas Therapeutics US Inc. | 1 | $25.78 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $20.52 |
| Xeris Pharmaceuticals, Inc. | 1 | $20.1 |
| Vifor Pharma, Inc. | 1 | $18.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.